Pro-Dex, Inc. (PDEX) P/E Ratio History
Historical price-to-earnings valuation from 1993 to 2026
Loading P/E history...
PDEX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Pro-Dex, Inc. (PDEX) trades at a price-to-earnings ratio of 21.5x, with a stock price of $57.42 and trailing twelve-month earnings per share of $3.67.
The current P/E is 27% above its 5-year average of 16.9x. Over the past five years, PDEX's P/E has ranged from a low of 9.6x to a high of 31.7x, placing the current valuation at the 80th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, PDEX is roughly in line with its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
The PEG ratio of 1.76 (P/E divided by 345% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, PDEX trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PDEX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PDEX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $4B | 29.3 | - | +5% | |
| $4B | 27.7 | 1.67Best | +18% | |
| $113B | 35.0 | 2.36 | +8% | |
| $16B | 23.5 | - | -20% | |
| $100B | 21.6Lowest | - | +31%Best | |
| $17B | 30.5 | - | -25% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PDEX Historical P/E Data (1993–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | $49.12 | $3.62 | 13.6x | -36% | |
| FY2026 Q2 | Wed Dec 31 2025 00:00:00 GM | $38.48 | $3.40 | 11.3x | -47% |
| FY2026 Q1 | $33.85 | $3.35 | 10.1x | -53% | |
| FY2025 Q4 | Mon Jun 30 2025 00:00:00 GM | $43.64 | $2.70 | 16.2x | -24% |
| FY2025 Q3 | Mon Mar 31 2025 00:00:00 GM | $49.58 | $2.80 | 17.7x | -17% |
| FY2025 Q2 | $46.75 | $2.01 | 23.3x | +9% | |
| FY2025 Q1 | Mon Sep 30 2024 00:00:00 GM | $29.85 | $1.54 | 19.4x | -9% |
| FY2024 Q4 | Sun Jun 30 2024 00:00:00 GM | $19.64 | $0.62 | 31.7x | +49% |
| FY2024 Q3 | Sun Mar 31 2024 00:00:00 GM | $17.60 | $1.21 | 14.5x | -32% |
| FY2024 Q2 | Sun Dec 31 2023 00:00:00 GM | $17.52 | $1.38 | 12.7x | -40% |
| FY2024 Q1 | Sat Sep 30 2023 00:00:00 GM | $15.70 | $1.48 | 10.6x | -50% |
| FY2023 Q4 | Fri Jun 30 2023 00:00:00 GM | $19.10 | $1.98 | 9.6x | -55% |
Average P/E for displayed period: 21.3x
See PDEX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PDEX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PDEX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPDEX — Frequently Asked Questions
Quick answers to the most common questions about buying PDEX stock.
Is PDEX stock overvalued or undervalued?
PDEX trades at 21.5x P/E, above its 5-year average of 16.9x. The 80th percentile ranking indicates a premium to historical valuation.
How does PDEX's valuation compare to peers?
Pro-Dex, Inc. P/E of 21.5x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is PDEX's PEG ratio?
PDEX PEG ratio is 1.76. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 1993-2026.